Monitoring Chemotherapy-Induced Alopecia With Trichoscopy

    Alfredo Rossi, Maria Caterina Fortuna, Gemma Caro, Michele Cardone, Valentina Garelli, Sara Grassi, Marta Carlesimo
    Image of study
    TLDR Chemotherapy caused hair loss with specific patterns, but most patients had hair regrowth after treatment, while some had lasting hair loss.
    The study investigated the trichoscopic patterns of chemotherapy-induced alopecia (CIA) in 12 women with breast cancer undergoing the FEC chemotherapy protocol. It found that after the first 3 weeks of chemotherapy, patients displayed specific trichoscopic features such as black dots, broken hairs, flame hairs, and pohl pinkus. At the end of chemotherapy, there was evidence of hair regrowth, but also signs of persistent alopecia with rare terminal hair and scattered black dots. Three months post-chemotherapy, there was an increase in follicular units and hair length. Before chemotherapy, 70% of patients had a normal trichoscopic appearance, but during treatment, various alopecia-related features were observed. After treatment, 80% of patients had complete hair regrowth, while 20% showed signs of persistent alopecia, possibly due to underlying female pattern hair loss or damage to hair follicle stem cells. The study highlighted the importance of continuous monitoring of CIA and suggested that further research is needed to understand the impact of chemotherapy on hair loss and regrowth.
    Discuss this study in the Community →

    Research cited in this study

    6 / 6 results

    Related Community Posts Join

    6 / 30 results

    Related Research

    5 / 5 results